Relmada Therapeutics, Inc. - Common Stock (RLMD)
0.3600
+0.0100 (2.86%)
Relmada Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for pain and related disorders
The company is dedicated to addressing unmet medical needs through its advanced therapeutic candidates, which aim to provide safe and effective alternatives to existing pain management options. By leveraging its expertise in neuroscience and pharmacology, Relmada Therapeutics is working towards advancing novel therapies that enhance the quality of life for patients suffering from chronic pain conditions and other neurological issues.
Frequently Asked Questions
Is Relmada Therapeutics, Inc. - Common Stock publicly traded?
Yes, Relmada Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Relmada Therapeutics, Inc. - Common Stock trade on?
Relmada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Relmada Therapeutics, Inc. - Common Stock?
The ticker symbol for Relmada Therapeutics, Inc. - Common Stock is RLMD on the Nasdaq Stock Market
What is the current price of Relmada Therapeutics, Inc. - Common Stock?
The current price of Relmada Therapeutics, Inc. - Common Stock is 0.3600
When was Relmada Therapeutics, Inc. - Common Stock last traded?
The last trade of Relmada Therapeutics, Inc. - Common Stock was at 1:29 pm EST on January 31st, 2025
What is the market capitalization of Relmada Therapeutics, Inc. - Common Stock?
The market capitalization of Relmada Therapeutics, Inc. - Common Stock is 6.29M
How many shares of Relmada Therapeutics, Inc. - Common Stock are outstanding?
Relmada Therapeutics, Inc. - Common Stock has 17.47M shares outstanding.